Abstract The metabolic pathway of cholesterol degradation by bacteria has not been completely established. Several possible intermediates have not been identified and many pathway delineations have not involved the use of the cholesterol molecule per se and just one bacterial species. The bacterial degradation of cholesterol by Pseudomonas sp. NCIB has been studied. Major biotransformation products included cholest-5-en-3-one, cholest-4-en-3-one, 26-hydroxycholest-4-en-3-one, androsta-1,4-dien-3-1 'Idione, cholest-4-en-3-one-26-oic acid, chol-4en-3-one-24-oic acid, pregn-4-en-3-one-20-carboxylic acid, and pregna-1,4-dien-3-one-20-carboxylic acid. Supplementary key words thin-layer chromatography gas-liquid chromatography nuclear magnetic resonance mass spectrometry a,a'-dipyridyl n-propanol T h e search for microorganisms that can decompose cholesterol began almost 40 years ago. Tak (1) observed in 1942 that several species of Mycobacteria could utilize cholesterol as the sole carbon source. Turfitt (2) revealed in 1947 that many strains of Proactinomyces were capable of up to 35% cholesterol decomposition. Later studies by Turfitt (3) revealed that it was possible to isolate metabolites of cholestenone from growing cultures of Proactinomycetes erythropolis. Products identified were 3-oxoetiocholest-4-enoic acid, A-nor-3,5-secocholest-5-en-3-oic acid, and isocaproic acid. In 1947 Horvath and Kramli (4) showed that a species of Azotobacter could transform cholesterol to cholestenone, 7-dehydrocholesterol and presented evidence for side-chain cleavage by also detecting methyl heptanone in the culture medium.
T h e search for microorganisms that can decompose cholesterol began almost 40 years ago. Tak (1) observed in 1942 that several species of Mycobacteria could utilize cholesterol as the sole carbon source. Turfitt (2) revealed in 1947 that many strains of Proactinomyces were capable of up to 35% cholesterol decomposition. Later studies by Turfitt (3) revealed that it was possible to isolate metabolites of cholestenone from growing cultures of Proactinomycetes erythropolis. Products identified were 3-oxoetiocholest-4-enoic acid, A-nor-3,5-secocholest-5-en-3-oic acid, and isocaproic acid. In 1947 Horvath and Kramli (4) showed that a species of Azotobacter could transform cholesterol to cholestenone, 7-dehydrocholesterol and presented evidence for side-chain cleavage by also detecting methyl heptanone in the culture medium.
Stronger evidence for cholesterol side-chain cleavage was provided by Whitmarsh (5) who showed that a Nocardia soil isolate could convert cholesterol to pregn-4-en-3-oxo-20-carboxylic acid, androst-4-en-3,17-dione (AD), and androsta-1,4-dien-3,17-dione (ADD) in the presence of 7-hydroxyquinoline. T h e use of inhibitors to enable detection of intermediary metabolites was utilized by In one study (6) they noted that complete decomposition of cholesterol could be achieved by many species of the genera Arthrobacter, Bacillus, Breuibacterium, Corynebacterium, Microbacterium, Mycobacterium, Nocardia, Protoaminobacter, Serrattia, and Streptomyces. Further work by this group (7) revealed that using the chelating agent a,a,'-dipyridyl (a,a'-D), cholesterol side-chain cleavage could be detected (as evinced by the detection of ADD) in all the above-mentioned genera. Parallel studies (8) revealed that a range of inhibitors, a,a'-D, orthophenanthroline, &hydroxy-quinoline, CuSo4, and NiS04, were the most efficient at causing cholesterol metabolite accumulation. They concluded that these agents exerted their effects by inhibiting 9a-hydroxylation of ADD.
In the same decade a different approach was followed by Sih, Wang, and Tai (9). Using Nocardia restrictus they demonstrated the production of 3-hydroxy-1 9-bisnorchola-l,3,5( 1 0)-trien-22-oic acid and 3-hydroxy-19-bisnorchola-l,3,5( lo), 17(2O)-tetraen-22-oic acid from 19-hydroxy-cholest-4-en-3-one (9) which supported the observation of Whitmarsh (5) in that the degradation of the hydrocarbon side-chain of cholesterol proceeds via CZ2 acidic intermediates. However, this study failed to show that the actual Cz2 acids isolated could be converted to ADD. In parallel studies (10) using radiolabeled cholesterol they also detected and identified 3-oxochol-4-en-24-oic acid. However, radiolabeled lithocholic acid was used to show that a C24 steroid could be converted to a Cz2 steroid with concomitant release of acetic acid. Sih, Wang, and Tai (1 1) confirmed their original work by eventually isolating four C22 acidic ste-roids from 19-hydroxy-cholest-4-en-3-one. In this study they also demonstrated the production of radiolabeled propionic acid during the conversion of 3-OXO-1 9-bisnorchol-4-en-22-oic acid to a 17-oxo-steroid. Subsequently, Sih and co-workers (1 2) using labeling studies established that Nocardia restrictus could convert cholesterol to 3-oxochola-1,4-dien-24-oic acid with the release of radioactive propionic acid. Again, labeled lithocholic acid was used to demonstrate acetic acid production.
On the basis of these studies Sih If the mechanism of sterol side-chain cleavage proposed by Sih et al. (9-12) is correct then it seems logical that the initial step in the sequential degradation of sterols involves functionalization of one of the terminal methyl groups. Zaretskaya et al. (14) have shown that such a reaction is carried out by a species of Mycobacterium when incubated with cholesterol as evinced by the production of 27-hydroxycholest-4-en-3-one.
Recently Wovcha et al. (15) have used mutants of Mycobacterium fortuitum, blocked at various stages in the degradation pathway of P-sitosterol, to accumulate intermediates including AD, ADD, ring A-degraded tricyclic compounds, and several 9a-hydroxysteroids.
Thus, the bacterial degradation of cholesterol and &sitosterol is fairly well understood. However, a complete pathway has yet to be elucidated involving the unmodified cholesterol molecule and using just one bacterial strain.
Because Pseudomonas sp. NCIB 10590 (Pseudomonas sp. 10590) has proved to be highly efficient in the degradation of bile acids (1 6-20) and grows well on cholesterol as sole carbon source, we have studied the aerobic metabolism of cholesterol by this strain. MATERIALS 5a-Cholestane and ADD were obtained from KochLight (Colnbrook, Bucks, England). Cholesterol, sodium deoxycholate (NaDCA) and ad-dipyridyl (a,a'-D) were obtained from BDH (Poole, Dorset, England). All reference steroids were 100% pure as judged by thinlayer chromatography (TLC) and gas-liquid chromatography (GLC). General reagents were of 'Analar grade' purchased from BDH, and all solvents (including n-propanol) were redistilled before use.
METHODS

Analytical
Infrared (IR) spectra, ultraviolet (UV) spectra, nuclear magnetic resonance (NMR) spectra, mass spectra (MS), and gas-liquid chromatographic-mass spectra (GLC-MS) were obtained as described previously (21) . TLC and GLC methodology was also carried out as described previously (2 1). Isolated metabolites obtained by preparative TLC were crystallized from the elution solvent (ethyl acetate) and recrystallized from methanol-dichloromethane 1 :9 unless otherwise stated. The biotransformation medium used, contained (g/l of distilled water): cholesterol, 0.5; KzHP04, 7.0; KHZPO4, 3.0; NaCI, 2.0; (NH4)$04, 1.0; KN03, 0.5; niacin, 0.01; biotin, 0.125; MgSO, 7Hz0, 0.10; CaCIz (dried), 0.01; and FeS04 -7 H z 0 , 0.005; final pH 7.0. The cholesterol carbon source (1 % solution) was prepared as a thick creamy suspension, by first dissolving 10 g in diethyl ether (30 ml) followed by an equal volume of distilled water, plus 0.2 ml of detergent (Lipsol; LIP Equipment and Services Ltd., Shipley, England). The mixture was agitated with an Ultraturrax homogenizer causing dispersal of the sterol into fine particles and evaporation of the diethyl ether. The solution was made up to 1 liter with distilled water prior to sterilization at 15 Ib per square inch for 20 min. Mineral salts, trace elements, and magnesium sulphate solutions were also sterilized separately prior to aseptic admixture.
The organism
Pseudomonas sp. 10590 was routinely maintained on slopes of the biotransformation medium solidified by the addition of 2% Agar No. 1. Additional stocks of the organism were also maintained on similar slopes in which cholesterol was substituted by NaDCA. Seed cultures for the cholesterol experiments were provided by growing Pseudomonas sp. 10590 to stationary phase on NaDCA as sole carbon source for 24 hr at which time the bile acid had been completely metabolized (as judged by TLC and GLC). T h e organism was grown in Erhlenmeyer shake-flask cultures on an LH Engineering orbital shaker (200 rev/min) at 28°C. 
Cholesterol metabolism in the absence of inhibitors
Cholesterol metabolism in the presence of inhibitors
T h e metabolism of cholesterol by Pseudomonas sp. 10590 in the presence of inhibitors was initially carried out in 250-ml Erhlenmeyer shake flasks containing 100 ml of biotransformation medium. Duplicate experiments were set up containing either a,a'-D (0-1 0 mM) or n-propanol (0-10%) to ascertain the optimum concentration and per cent of inhibition, respectively, of inhibitor required to cause maximum metabolite accumulation. T h e cultures were seeded with Pseudomonas sp. 10590 and were incubated for 48 hr at 28°C. T h e inhibitors were added and incubation was continued for a further 24 hr. Analysis of ethyl acetate extracts (methylated with ethereal diazomethane (22) ) was carried out by GLC. Neutral steroids were quantitated with reference to the flame ionization response of 5a-cholestane and acidic steroids by reference to methyl DCA. Both reference steroids were added to the cultures prior to extraction. A l-liter fermentation of cholesterol (0.5 mg/ml) by Pseudomonas sp. 10590 was carried out for 48 hr at 28°C. Analysis of a culture aliquot (10 ml) by T L C and GLC revealed the presence of cholesterol and metabolite B only. a,a'-D (0.6 mM) was added to the medium and incubation was continued for a further 24 hr. At the end of the fermentation the medium was extracted with ethyl acetate to yield 270 mg of dried residue. T h e residue was dissolved in 50 ml of ethyl acetate, washed twice with distilled water (75°C) to remove a,a'-D, and was dried again to give 254 mg of residue. T h e dried residue was separated by preparative T L C (15 plates) into a series of fractions from which steroids B-H were crystallized.
Cholest-4-en-3-one (B). Recrystallization of metabolite B gave white crystals (87 mg).
Androst-4-en-3,17-dione (C). Recrystallization of metabolite C gave white crystals (8 mg), mp 164°C. IR 1736 (1 7-ketone), 1666 (3-ketone), and 16 Cholest-4-en-3-one-26-oic acid (0). Metabolite 0 could not be crystallized, but was obtained as a dry gummy residue (10 mg). Analysis of this compound however showed it to be identical to cholest-4-en-3-one-26-oic acid synthesized by Jones' chromic oxidation of 26-hydroxycholesterol. Analysis of the methyl ester derivative revealed IR 1740 (26-COOCH3), 1700 (3-ketone) and 1610 cm-' (C4-C5 double bond); UV 243 nm. GLC, Rr 15-20; TLC, R, 1.31; after oxidation, R, 1.31; after acetylation, R, 1.3 1; and after reduction, Rf 1.3 1.
Metabolite P also could not be crystallized but formed a yellow gummy residue (2 mg). This compound was identical in its properties to the Jones' chromic oxidation product of 26-hydroxycholesta-1,4-dien-3-0ne. Analysis of the methyl ester of P revealed IR 1750 (26-COOCHs), 1660 (3-ketone), 1610 and 1600 cm-' (CI-C2 and C4-
Cholesta-1,4-dien-3-one-26-oic acid (P).
Owen, Mason, and Bilton Degradation of cholesterol by Pseudomonas sp. NCIB 10590 
Cholesterol intermediary metabolism
T o elucidate more clearly the sequential nature of cholesterol side-chain cleavage, the major presumptive intermediates in the pathway were incubated with Pseudomonas sp. 10590 in the presence of the relevant inhibitors. T h e experiments were carried out in duplicate with culture volumes in the range 10-250 ml depending upon the amount of available substrate. Neutral steroid substrates (0.02%) were prepared in the same way as cholesterol whilst acidic substrates (0.02%) were prepared as sodium salts. Procedures were identical to the large scale experiments and major metabolites of intermediary metabolism were identified by T L C and GLC.
RESULTS
Pseudomonas sp. 10590 gave confluent growth on agar plates containing cholesterol and in aqueous media showed the capacity to degrade the sterol completely after 72 hr incubation. During the biodegradation period a transient metabolite appeared which reached a maximum after 48 hr growth. Analysis of this metabolite (B) revealed it to be identical to authentic cholest-4-en-3-one (4CTO) in its chromatographic and spectroscopic properties. Side-chain cleavage products were not detected under these conditions. This is in complete contrast to bile acid degradation by the Pseudomonas sp. under similar conditions (1 6-20). Typically during the metabolism of chenodeoxycholic acid (1 7) after an initial lag phase, C19 and C22 side-chain cleavage products reached a maximum at 12 hr and 14.5 hr, respectively.
In the presence of selective enzyme inhibitors such as a,a'-D and n-propanol, a number of metabolites built up in the medium during the fermentation of cholesterol by Pseudomonas sp. 10590. Maximum metabolite accumulation occurred with 0.6 mM a d -D and 2% npropanol, respectively.
Cholesterol fermentation in the presence of a,cr'-D
Pseudomonas sp. 10590 grew fairly rapidly on cholesterol mineral salts medium of pH 7.0 at 28OC. T h e course of the fermentation was followed by T L C analysis of ethyl acetate extracts of culture aliquots; the extent of UV absorbance at 242 nm of the dried extracts (taken up in methanol) indicated the amount of ring-A ap-unsaturated ketone present. T h e absorbance of 4 C T 0 reached a maximum after 48 hr and then rapidly decreased. However, after addition (48 hr) of 0.6 mM a,a'-D, the decrease was very slight at 72 hr. A 1-liter culture was extracted after 72 hr. Separation of the extract by preparative TLC yielded a major neutral metabolite (B) and two minor metabolites (C and D) (Fig. l) , with one major acidic metabolite (H), and several minor acidic metabolites (E-G) (Fig. 2) .
Compound B was identical to authentic 4 C T 0 in its chromatographic and spectroscopic properties. T h e minor neutral metabolites C and D were identical to authentic androst-4-en-3,17-dione and androsta-l,4-dien-3,17-dione, respectively, in their chromatographic and spectroscopic properties.
T h e major acidic metabolite (H) was isolated as a crystalline solid. T h e methyl ester of H gave a mass spectrum showing a low intensity molecular ion at m/e 356 and an intense (base peak) ion at m/e 122, suggesting a steroidal 1,4-dienone structure (23) . Confirmation of the structure of ring A was provided by the IR spectrum (1672, 1628, and 1608 cm-', ap-unsaturated ketone), the UV spectrum (A max 244 nm, di-@-substituted ap-unsaturated ketone in a six-membered ring, double bond exocyclic) (24) and by the PMR spectrum (three vinylic protons in the range 6 6.05-7.01 ppm). Compound H could not be oxidized, acetylated, or reduced, inferring the absence of hydroxyl groups and unconjugated ketone groups. T h e mass spectrum of the methyl ester of H also showed a low intensity ion at m/e 269 corresponding to the loss of a 4-carbon side chain from C17. Compound H was therefore assigned the structure 3-oxo-pregna-1,4-dien-2O-carboxylic acid. Of the minor acidic compounds, metabolite G gave a mass spectrum showing a molecular ion at m/e 358 and an intense (base peak) ion at m/e 124, suggesting a steroidal 4-en-3-one structure (23) . Confirmation of the structure of ring A was provided by the IR spectrum (1 670, 16 16 cm-', ap-unsaturated ketone) the UV spectrum (A max 24 1 nm, di-P-substituted @-unsaturated ketone, double bond exocyclic) (24) and by the proton magnetic resonance (PMR) spectrum (one vinylic proton at 6 5.7 1 ppm). Compound G could not be oxidized, acetylated, or reduced, inferring the absence of hydroxyl groups and unconjugated ketone groups. T h e mass spectrum of methyl G also showed a low intensity ion at m/e 271 corresponding to the loss of the side chain from C I 7 . Compound G was therefore assigned the structure 3-oxo-pregn-4-en-20-carboxylic acid.
Another minor acidic metabolite (E) showed an intense molecular ion at m/e 386 and an intense ion at m/e 124, inferring a steroidal 4-en-3-one structure. Confirmation of this structure was obtained from the IR, UV, and PMR spectra. T h e mass spectrum of methyl E also showed a low intensity ion at m/e 271 corresponding to the loss of the full bile acid side chain (6-carbon) from C17. Compound E was therefore assigned the structure chol-4-en-3-one-24-oic acid.
T h e remaining acidic metabolite (F) showed a low intensity molecular ion at m/e 384 and an intense (base peak) ion at m/e 122 suggesting a steroidal 1,4-dienone structure. This was confirmed by the UV, IR, and PMR spectra. T h e mass spectrum of methyl F also showed a low intensity ion at m/e 269 corresponding to the loss of the full bile acid side chain. Compound F was therefore assigned the structure chola-1,4-dien-3-0ne-24-oic acid.
Cholesterol fermentation in the presence of 2% n-propanol
When 2% n-propanol was added during the log phase of growth (48 hr) of Pseudomonas sp. 10590, a build-up of metabolites occurred (some of which had not been observed previously). A l-liter culture was extracted after 72 hr. Separation of the extract gave a major neutral component (B) and seven minor neutral components (compounds D, I-N) (Fig. l) , with one major acidic component (0) and three minor acidic components (compounds E, H, and P) (Fig. 2) .
Compound B and one of the minor neutral metabolites (D) were identical to authentic 4 C T 0 and androsta-l,4-dien-3,17-dione, respectively. One of the minor neutral compounds (I) was identical in its chromatographic and spectroscopic properties to cholest-5-en-3-one. Of the five remaining neutral metabolites, compound J revealed an intense molecular ion at m/e 400 and an intense ion at m/e 124 suggesting a steroidal 4-en-3-one structure. Confirmation of the structure of ring A was provided by the IR spectrum (1660 and 1610 cm-I, aa-unsaturated ketone) and UV spectrum (A max 24 1 nm, di-&substituted ap-unsaturated ketone, double bond exocyclic) and by the PMR spectrum (one vinylic proton at 6 5.70 ppm). The PMR spectrum also revealed singlet signals due to the protons of the angular methyl groups at C18 (6 0.70 ppm) and at CI9 (6 1.18 ppm) as well as two partially overlapping doublets (J = 7Hz) at 6 0.89 ppm and at 0.93 ppm belonging to two methyl groups coupled with a neighboring methine proton. The spectrum also contained a doublet signal (5 Hz) at 6 3.46 ppm equal to a 2-proton signal. The chemical shift of this signal indicated that the corresponding protons were located close to an oxygen atom and thus interaction was occurring with the hydroxyl proton according to the spin-spin mechanism. This indicated that the molecule contained a primary hydroxyl group. Compound J could be acetylated with acetyl chloride further substantiating the presence of a hydroxyl group, but could not be reduced indicating the absence of an unconjugated ketone group. This was confirmed by the IR spectrum which displayed a significant peak (3490 cm-I) in the hydroxyl group region. The primary nature of the hydroxyl group and its location was also proved when compound J was oxidized with Jones' chromic reagent (25) . This produced a metabolite which after methylation was identical to methyl %oxo-cholest-4-en-3-one-26-oic acid synthesized by the same method from 26-hydroxycholesterol. Compound J was therefore assigned the structure 26-hydroxycholest-4-en%one.
Another of the neutral components, compound (K), was isolated as pale orange crystals. The mass spectrum of K revealed an intense molecular ion at m/e 398 and an intense ion at m/e 122 indicative of a steroidal 1,4-dienone structure. Confirmation of the A-ring structure was provided by the UV and IR spectra. Compound K was easily acetylated but could not be reduced, suggesting the presence of a hydroxyl group. This was confirmed by the IR spectrum. The location of the hydroxyl group was again proved by oxidation of K with Jones' reagent. This produced a metabolite which after methylation was identical to methyl 3-oxo-cholest-1,4-dien-3-one-26-oate synthesized from methyl 3-oxo-cholest-4-en-26-oate by DDQ oxidation (26) . Compound K was therefore assigned the structure 26-hydroxycholesta-1,4-dien-3-0ne.
Two (L and M) of the three remaining metabolites appeared to be structurally related. The mass spectrum of L showed a base peak molecular ion at m/e 302 and an intense ion at m/e 124 suggestive of a steroidal 4-en-3-one structure. Confirmation of this structure was provided by the UV and IR spectra. Compound L could not be oxidized but was readily acetylated and reduced indicating the presence of a hydroxyl group and an unconjugated ketone group. The fact that the hydroxyl group could not be oxidized inferred that it was in a tertiary position. The position of the hydroxyl group was ascertained from the mass spectrum which showed an ion of low intensity at m/e 137. This is characteristic of Sa-hydroxy-4-en-3-oxo steroids and the fragment is produced by cleavage between Cg and Clo followed by cleavage at Ct and C8 (27) . Compound L was therefore assigned the structure 9a-hydroxyandrost-4-en-3,17-dione.
The mass spectrum of compound M showed a base peak molecular ion at m/e 300 and an intense ion at m/e 122 indicative of a steroidal 1,4-dienone structure.
Compound M could not be oxidized, but was readily acetylated and reduced indicating the presence of a hydroxyl group and an unconjugated ketone group. The fragment ion at m/e 135 was again suggestive of a 9a-hydroxy A-ring unsaturated steroid. Compound M was therefore assigned the structure Sa-hydroxyandrosta-1,4-dien-3,17-dione.
The final neutral metabolite (N) isolated was recognized as a phenolic compound initially by its UV spectrum X max 283 nm, which underwent a bathochronic shift on addition of base to X max 292 nm. The compound, when sprayed with Folin and Ciocalteau reagent on TLC and developed in an atmosphere of ammonia, gave a characteristic blue color which is specific for phenolic hydroxyl groups. The mass spectrum of N shows a molecular ion at m/e 300 and an intense ion at m/e 134 which is typical of 9,1 O-secosteroids. The compound formed a monotrimethyl silyl-ether with a molecular ion at m/e 372 indicating the presence of one hydroxyl group. The base peak of the spectrum was at m/e 206 suggesting that the hydroxyl group was attached to ring A. Compound N could not be oxidized, but was readily acetylated and reduced, thus inferring the presence of a hydroxyl group and unconjugated ketone groups. This was confirmed by the IR spectrum which displayed two peaks in the unconjugated ketone group region at 1740 and 1705 cm-' and one peak in the hydroxyl group region at 3360 cm-'. The IR spectrum also showed the following peaks at 1608, 1585, and 1500 (aromatic ring), 1280 and 1250 (phenol) and at 856 and 800 cm-' (0, m-substituted phenol ring) which are typical of phenolic steroids. Compound N was therefore assigned the structure 3-hydroxy-9,1 O-seco-1,3,5( lO)-androstatrien-9,17-dione.
The major acidic metabolite (0) was isolated as a dry gummy residue. The methyl ester was identical in its TLC, GLC, and spectroscopic properties to methyl-3-oxo-cholest-4-en-26-oate synthesized from 26-hydroxycholesterol. The unsaturated nature of the A ring was provided by the UV spectrum (A max, 243 nm, di-@-substituted a@-unsaturated ketone, double bond exocyclic) and by the IR spectrum (1 700 and 16 10 cm-' , ap-unsaturated ketone). Compound 0 could not be oxidized, acetylated, or reduced indicating the lack of hydroxyl and free ketonic groups. Because insufficient material was available for mass spectra and PMR analysis, this metabolite was tentatively assigned the structure cholest-4-en-3-one-26-oic acid.
One of the minor acidic metabolites (P) was also isolated as a gummy residue. The methyl ester was identical in its TLC, GLC, and spectroscopic properties to methyl 3-oxo-cholesta-1,4-dien-26-oate synthesized from 26-hydroxycholesta-1,4-diene-3-0ne. The unsaturated nature of ring-A was confirmed by the UV spectrum (A max 246 nm) and by the IR spectrum (1660, 1610, and 1600 cm-'). Compound P could not be oxidized, acetylated, or reduced indicating the absence of hydroxyl groups and unconjugated ketone groups. Again lack of material for MS and PMR analyses enabled only a tentative assignation of structure, namely cholesta-l,4-dien-3-one-26 oic acid.
The remaining minor metabolites (E and H) were found to be identical to chol-4-en-3-one-24-oic acid and pregna-1,4-dien-3-2O-carboxylic acid, respectively.
Cholesterol intermediary metabolism
The results (Table 1) In Pseudomonas sp. 10590, the first reaction of cholesterol catabolism is 3P-hydroxysteroid dehydrogenation which is catalyzed by an NAD requiring 3P( 17P)-hydroxysteroid dehydrogenase rather than the cholesterol oxidase found in Arthrobacter (6) and Nocardia spp.
DISCUSSION
Past studies on the bacterial catabolism of cholesterol have been limited by the lack of accumulated intermediates. In the absence of specific enzyme inhibitors, the (28). In the above organism, this enzyme is located in the periplasmic space (29) and thus may be involved in sterol functionalization necessary for binding to transport proteins (30) prior to further degradative reactions mediated in the cytosol.
We isolated the first product, cholest-5-en-3-one (4% yield at 27 hr) using n-propanol-inhibited cholesterol cultures. This product does not normally accumulate and is rapidly isomerized to 4CTO. 4 C T 0 , the sole accumulation product at 48 hr in uninhibited aerobic cholesterol cultures, does not appear to be a good substrate for the A' dehydrogenase because the 1,4-dienone does not accumulate in either normal or inhibited fermentations.
In non-inhibited cultures, 4 C T 0 reaches a concentration of 360 mg/liter (36%) after 48 hr. N o steroidal material was detectable at 72 hr. In contrast, 4 C T 0 persisted at 170 mg/liter (1 7%) after 72 hr in ad-D-treated cultures and at 463 mg/liter (46% yield) when n-propanol was used. Thus 4 C T 0 is always the major accumulation product indicating in this organism and perhaps many others that the rate-limiting step in cholesterol degradation is functionalization at C26.
The accumulation of intermediates with oxygen functions at C26 occurred only in the n-propanol-inhibited fermentations. Evidence for 26-hydroxycholest-4-en-3-one and the A' homologue indicates that side-chain functionalization is probably via a cytochrome P,,,,-mediated hydroxylation of the c 2 6 methyl group and sequential oxidation via the CZ6 aldehyde to the c 2 6 carboxylic acid involving alcohol and aldehyde dehydrogenases. Evidence from our earlier work on steroid dehydrogenases (29) leads us to suggest that these reactions also may occur in the periplasmic space. In the absence of any alternative evidence, it is presumed that steroid side-chain removal is mediated by sequential @-oxidation. The next reaction, namely thiokinase-mediated activation of the carboxylic acid group at c 2 6 to the acyl CoA derivative, must therefore occur in the cytoplasm. T h e first products of sidechain cleavage, namely chol-4-en-3-one-24-oic acid (metabolite E) and its A' homologue (metabolite F) (very low concentrations) accumulate in both a,&'-D and n-propanol-treated cultures, and are identical in structure to the early products of lithocholate metabolism by Pseudomonas sp. 10590 (3 1). These intermediates are degraded to CZ2 derivatives (bisnor acids) which accumulate mainly in a,a'-D cultures. Interestingly, the A14 bisnor acid predominates over its A4 homologue (5%:2.2%) and indicates that partial side-chain removal results in the formation of a more effective substrate for the A'-nuclear dehydrogenase.
The final reaction of side-chain cleavage results in the formation of C19 ketosteroids with ADD predominating. In a study of androstane degradation, Dodson and Muir (32) . Further degradation of secophenols has been described in detail by Miclo and Germain (33) . It has also been demonstrated that loss of the steroid nucleus can occur via oxidative attack at C4 to yield cholest-4-en-3-one-4-01 and ultimately Windaus oxo-acids (34 
